Cystic Fibrosis News Today — Synedgen Presents New CF Complication Treatment Options at North American Cystic Fibrosis Conference

Researchers at Claremont, California-based biotechnology company Synedgen are developing targeted therapies that address complications of cystic fibrosis (CF) on pulmonary and GI surfaces for which only limited treatment options are currently available — an unmet need frequently leading to early mortality. Cystic Fibrosis News Today